We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

This study has been terminated.
(Reactogenicity met study halting criteria)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00866476
First Posted: March 20, 2009
Last Update Posted: April 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
PATH
Information provided by (Responsible Party):
Karen Kotloff, University of Maryland
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: April 20, 2017